7 medtech stories we missed this week: August 11, 2017
[Image from unsplash.com]From Xtant Medical’s 510(k) extension to Varian Medical’s distribution deal, here are seven medtech stories we missed this week but thought were still worth a mention. 1. FDA extends Xtant Medical’s 510(k) for Calix C spinal implant Xtant Medical announced in an Aug. 9 press release that the FDA has cleared its product line extensions for the Calix-C cervical inter body cages. The clearance allows for two larger footprints to be added for use with allograft. The Calix-C Cervical Interbody Spacer is designed for spinal fusion procedures at level one in patients who are skeletally mature. It is supposed to be used with spinal fixation systems like Xtant Medical’s Spider Cervical Plating and Certex Spinal Fixation Systems. 2. Life Spine touts first use of TiBow spacer Life Spine has announced the first clinical use of its TiBow MIS TLIF Expandable Spacer System with Osseo Loc Surface Technology in an Aug. 8 press release. TiBow is designed for in-situ expansion for increased endplate coverage and stability for minimally invasive TLIF and oblique approaches. It gives the surgeon the ability to restore sagittal alignment. 3. Cardiac Science inks deal to supply AEDs to Philadelphia schools Cardiac Science announced in an Aug. 8 press release that it has reached a deal with the School District of Philadelphia to make automated external defibrillators (AEDs) available in all 220 Philadelphia schools. Philadelphia’s high...
A new study finds that fecal hemoglobin can indicate more than an increased risk for colorectal cancer and is tied to an increased risk for all-cause mortality.Medscape Medical News
The F.D.A. announced that batches of a widely used generic drug, valsartan, made in China, might be tainted with a probable cancer-causing ingredient.
The objective of this study was to evaluate the distance of the crest of alveolar ridge to the cementoenamel junction (CEJ) of the lower second molars and the bone density of the third molar socket filled with Gen-Tech ®, 5 years after an exodontia using cone beam computed tomography (CBCT) to visualize the central region of the sockets, without overlapping of the buccal and lingual cortical bones. Material and Methods A total of 12 individuals from an initial group of 39 patients submitted to extraction of the unruptured lower third molars and grafting of an association of inorganic bovine bone matrix, organic bovine ...
THE test for bowel cancer may also provide some insight into whether patients are at risk of other health problems, a study suggests. Detecting "hidden" blood in stool is a commonly used method for bowel cancer screening.
Newest Advances and Strategies in Prostate Cancer: Science and Stories on the Evolving Treatment Landscape and Implications for Patient Care
Germline BRCA mutations and other HR genes may offer biomarkers for response to this treatment.
The statement emphasizes strategies for multidisciplinary care, and proposes an algorithm for clinical management of bone metastasis in RCC.
Relationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first-line panitumumab therapy: retrospective analyses of the PRIME and PEAK clinical trials, Published online: 17 July 2018; doi:10.1038/s41416-018-0165-zRelationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first-line panitumumab therapy: retrospective analyses of the PRIME and PEAK clinical trials
MicroRNAs (miRNAs) have emerged as crucial regulators of T lymphocyte survival, differentiation and function, all of which are key factors impacting the outcome of adoptive T cell-based immunotherapy. It has become increasingly clear that the adoptive transfer of memory CD8+ T cell subsets is highly correlated with objective clinical responses for patients with advanced cancer. However, it is unclear how to improve the long-term persistence of transferred CD8+ T cells using miRNAs. Here, we highlight the current advances in our understanding of the role of miRNAs in regulating the differentiation of memory CD8+ T cells. We...
Conclusions: Circulating HDL is significantly associated with treatment outcomes in patients with locoregionally advanced NPC. We suggest that HDL measurements will be of great clinical significance in the management of NPC.Cell Physiol Biochem 2018;48:285 –292
More News: Anatomy | Australia Health | Back Curves | Bone Graft | Brachytherapy | Cancer | Cancer & Oncology | Cancer in Adolescents | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Cervical Cancer | Clinical Trials | Endoscopy | Esophagus Cancer | Heart | Men | Radiation Therapy | Rectal Cancers | Science | Scoliosis | Study | Ultrasound | Upper Endoscopy